Skip to content

Psoriasis is an inflammatory immune-mediated disease that affects the skin and has pathogenic effects with systemic impact

To date, the pathogenesis of Ps and PsA remains unknown. Nowadays, Ps is considered an immune-mediated skin disease, and PsA regarded as a seronegative (rheumatoid factor negative) arthritis. Chronic inflammatory systemic diseases could share common immune-mediated inflammatory pathways. Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. Dermatologic manifestations of systemic illnesses such as the rash of secondary syphilis may also be confused with psoriasis. Epidermal skin tissue affected by psoriatic inflammation often has many CD8+ T cells while a predominance of CD4+ T cells make up the inflammatory infiltrates of the dermal layer of skin and the joints. Researchers have proposed differing descriptions of psoriasis and psoriatic arthritis; some authors have classified them as autoimmune diseases 15 31 57 while others have classified them as distinct from autoimmune diseases and referred to them as immune-mediated inflammatory diseases. Impact Factor 1.579. Further understanding of the disease has led to current areas of research aiming at the development of selective molecular targets to suppress the pathogenic immune responses. Psoriasis is an immune-mediated skin disease appearing in a chronic recurring manner. However, now it is widely accepted that T helper (Th)1 and Th17 lymphocytes contribute to the disease pathogenesis through the release of inflammatory cytokines that promote further recruitment of immune cells, keratinocyte proliferation, and sustained chronic inflammation 4, 5. Systemic retinoids are associated with several adverse effects including teratogenicity, serum lipid elevations, mucocutaneous toxicity, skeletal changes, and hair loss 30.

Psoriasis is an inflammatory immune-mediated disease that affects the skin and has pathogenic effects with systemic impact 2Psoriasis is a common immune-mediated inflammatory disease that affects the skin and joints. Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. In acute inflammatory or exanthematic psoriasis, scaling can be minimal and erythema may be the predominant clinical sign. Stress in the form of pathological worry has a deleterious effect on response to therapy. Lomholt G. Prevalence of skin disease in a population: A census study from the Faroe islands. Psoriasis is a common, chronic, immune-mediated inflammatory skin disease with potential systemic complications. Psoriasis may cause significant quality of life issues, even in mild cases, and is associated with excess all-cause mortality in patients with severe disease.1-7 Current epidemiological studies have demonstrated that psoriasis affects anywhere from 0. 34 The study demonstrated that psoriatic patients who received either methotrexate or TNF inhibitors had a significantly reduced risk of composite cardiovascular endpoint events, whereas no protective effect was seen with cyclosporine, retinoids and the IL-12/23 inhibitor ustekinumab (Stelara, Janssen Biotech, Inc.

The Genetics of Psoriasis: A Complex Disorder of the Skin and Immune System. Given that psoriasis has characteristics of an autoimmune disease, it is not surprising that HLA studies revealed an association with certain alleles, notably HLA-Cw6. The immune system has been strongly implicated in the pathogenesis of psoriasis since it resembles a T cell-mediated autoimmune disease (reviewed in refs 52 54). Whether this correlation reflects a true effect of the chromosome 6 phenotype, or would disappear if larger numbers of families were tested, remains to be determined. Psoriasis is one of the most common immune-mediated chronic, inflammatory skin diseases characterized by hyperproliferative keratinocytes and infiltration of T cells, dendritic cells, macrophages and neutrophils. It has been reported that there were more Th22 cells along with Th1 and Th17 cells in the circulation of psoriatic patients. Psoriasis is a phenotypically heterogeneous, immune-mediated skin condition that often follows a relapsing and remitting course. Approximately one third of patients have moderate to severe disease, which affects more than 10 of body surface area, and usually necessitates systemic medications. This promotes the recruitment and activation of further inflammatory cells such as neutrophils and macrophages, contributing to the formation of an inflamed cutaneous plaque. Indeed, genes that are synergistically regulated by IL-17 and TNF were more effectively blocked by anti-IL-17A than TNF antagonists 102, suggesting that IL-17A may have a dominant pathogenic effect.


A pathogenic memory within the skin has been proposed, but the nature of such site-specific disease memory is unknown. Psoriasis is an immune-mediated disorder primarily affecting the skin. Epidermal CD8 T cells play a critical role in psoriasis inflammation, and in agreement with previous reports (2, 18), we found that the majority of epidermal CD8 T cells in active psoriasis lesions expressed IL-17A, IL-22, and/or IFN-. Systemic sclerosis is an autoimmune disease characterized by inflammation and fibrosis of the skin and internal organs. Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study. We discuss the effect on cancer risk of different drug classes used in the treatment of IMIDs treatment, including biologicals such as tumor necrosis factor (TNF) inhibitors. Both diseases are characterized by severe gastrointestinal inflammation, although they also have systemic manifestations affecting the skin, eyes, joints, liver, hepatobiliary system 1, 67. Psoriasis is a chronic inflammatory skin disease characterized by circumscribed, erythemato-squamous plaques with adherent scales 72. Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients. Psoriasis vulgaris is a chronic, debilitating skin disease that affects millions of people worldwide. Individuals with moderate-to-severe psoriasis often receive rotational’ therapy, whereby drugs are changed after a certain time period to minimize the toxicity of a particular systemic treatment. This gene encodes an anti-inflammatory innate immune cytokine in the IL-1 family, and implicates the innate immune system in this systemic presentation of psoriasis. Thus, blocking either of these pathways (TNF or IL-23 Th17) might have dramatic effects on keratinocyte production of pathogenic downstream molecules. Despite being an immune-mediated condition that has many systemic effects, it is often considered to be simply a cosmetic or skin disorder. Approximately 30 of patients with psoriasis will also develop psoriatic arthritis, when the inflammatory process moves beyond the skin and affects the joints. There are multiple factors involved in the pathogenesis of psoriasis and psoriatic arthritis, including genetic variations, lifestyle components, history of infection, and altered gut flora. Psoriasis is a chronic inflammatory skin condition that is often associated with systemic manifestations. More severe psoriasis may be treated with phototherapy, or may require systemic therapy. Biologic therapies, including tumor necrosis factor inhibitors, can be effective for severe psoriasis and psoriatic arthritis, but have significant adverse effect profiles and require regular monitoring. Psoriasis is an immune-mediated disease with genetic predisposition, but no distinct immunogen has been identified.

The Genetics Of Psoriasis: A Complex Disorder Of The Skin And Immune System

Psoriasis is a chronic inflammatory disease mediated by a complex interplay between immune system and keratinocytes. (IL)-17 and IL-22, and have other important downstream proinflammatory effects on skin, leading to clinical and pathological features typical of psoriasis. Nowadays, emerging evidence suggests integrative and complicated inflammatory circuits among Th1 and Th17 cells and keratinocytes in the pathogenesis of psoriasis, with Th17 cells playing a central role. Studies investigating the effect and molecular mechanism of conventional and biological therapy for psoriasis on the IL-23/Th17 pathway were also discussed. Summing, it has effect on lineages, such as CD4 and CD8 T cells, regulatory T cells, B cells, natural killer cells, and dendritic cells, as well as on nonimmune cells. Chronic inflammatory skin diseases are a broad group that share similar characteristics with other inflammatory/autoimmune disorders, including a complex pathogenesis often with unknown etiology, systemic inflammation, and multiorgan involvement. Skin Diseases Psoriasis is a polygenic, multifactorial, immune-mediated disorder and may be considered as a prototype of chronic inflammatory skin diseases.